EpiPen Prices, the Clinton Foundation, and Lead Exposure

Why did EpiPen's price skyrocket 400 percent over the past decade? Sarah and Matt dive into the complex world of American drug pricing to find out. Also on this episode: understanding why the Clinton Foundation gets so much scrutiny, and a white paper of the week that shows how problematic a small level of lead exposure can be. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Aug 31, 2016

Embed this episode

Attribution link and audio player

NOW PLAYING

EpiPen Prices, the Clinton Foundation, and Lead Exposure

0:00 55:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Explain It to Me?

This episode is 55 minutes long.

When was this Explain It to Me episode published?

This episode was published on August 31, 2016.

Can I download this Explain It to Me episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!